000 01481 a2200409 4500
005 20250515185224.0
264 0 _c20100201
008 201002s 0 0 eng d
022 _a1098-6596
024 7 _a10.1128/AAC.00728-09
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aXu, Rong
245 0 0 _aPhase I evaluation of the safety and pharmacokinetics of a single-dose intravenous injection of a murine monoclonal antibody against Hantaan virus in healthy volunteers.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cDec 2009
300 _a5055-9 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aAntiviral Agents
_xadministration & dosage
650 0 4 _aArea Under Curve
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aFemale
650 0 4 _aHalf-Life
650 0 4 _aHantaan virus
_ximmunology
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aYoung Adult
700 1 _aYang, Xiao Yan
700 1 _aYang, Dao Feng
700 1 _aZou, Chang Yong
700 1 _aGong, Pei Li
700 1 _aZeng, Fan Dian
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 53
_gno. 12
_gp. 5055-9
856 4 0 _uhttps://doi.org/10.1128/AAC.00728-09
_zAvailable from publisher's website
999 _c19150248
_d19150248